Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Lombard Medical
Age
21–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosed abdominal aortic aneurysm \> 4.5 cm in diameter, OR 4.0 cm or larger in diameter if symptomatic (i.e. pain, embolization), OR documented AAA growth of more than 5 mm within the previous 6 months, and/or including extension into common iliac artery (ies), and/or
Iliac aneurysm greater than, or equal to 3.5 cm in maximum diameter.
You may not be if
Less than 21 years of age,
Life expectancy less than 2 years,
Pregnant,
Religious cultural or other objection to the receipt of blood or blood products,
Unwilling to comply with follow-up schedule,
Unwillingness or inability to provide informed consent to both trial and procedure.
Patients not expected to live more than 2 years from enrollment
Patient has a ruptured aneurysm
Aneurysm extends above renal arteries
Proximal neck of aneurysm has significant loose thrombus associated with it
Patient with an acute or chronic aortic dissection or mycotic aneurysm
Patient has current non-localized infection (may be recruited following remission of the infection)
Patient is allergic to device materials
Patient is allergic to or intolerant of use of contrast media and cannot be exposed to suitable remedial treatment such as steroids and/or benadryl
Patient is clinically and morbidly obese such that imaging would be severely adversely affected
Patient has renal failure (serum creatinine \> 2.5 mg/dL)
Patient has an uncorrectable bleeding abnormality
Patient has unstable angina
Patient is receiving dialysis:
Inflammatory aneurysm
MI in last 6 months
End stage COPD
Patient has connective tissue disease (eg Marfan syndrome, Ehlers-Danlos syndrome)
Significant (\>80%) renal artery stenosis which cannot be readily treated
Clareo Health | Prospective Aneurysm Trial: High Angle Aorfix™ Bifurcated Stent Graft
